Literature DB >> 19709144

Gestational diabetes: fasting capillary glucose as a screening test in a multi-ethnic, high-risk population.

M M Agarwal1, G S Dhatt, Y Othman, R Gupta.   

Abstract

AIMS: In populations at high risk of gestational diabetes mellitus (GDM), screening every pregnant woman by an oral glucose tolerance test (OGTT) is very demanding. The aim of this study was to determine the value of the fasting capillary glucose (FCG) as a screening test for GDM.
METHODS: FCG was measured by a plasma-correlated glucometer in 1465 pregnant women who underwent a one-step diagnostic 75-g OGTT for universal screening of GDM.
RESULTS: One hundred and ninety-six (13.4%) women had GDM as defined by the criteria of the American Diabetes Association. The area under the receiver operating characteristic curve (AUC) of the FCG was 0.83 (95% confidence interval 0.80-0.86). A FCG threshold of 4.7 mmol/l (at an acceptable sensitivity of 86.0%) independently could rule-out GDM in 731 (49.9%) women, while the FCG could rule-in GDM (100% specificity) in 16 (1.1%) additional women; therefore, approximately half of the women would not need to continue with the cumbersome OGTT.
CONCLUSIONS: Screening using a FCG significantly reduces the number of OGTTs needed for the diagnosis of GDM. Wider assessment, particularly in low-risk populations, would confirm the potential value of the FCG as a screening test for GDM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19709144     DOI: 10.1111/j.1464-5491.2009.02765.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

1.  Fasting capillary blood glucose: an appropriate measurement in screening for diabetes and pre-diabetes in low-resource rural settings.

Authors:  X Zhao; W Zhao; H Zhang; J Li; Y Shu; S Li; L Cai; J Zhou; Y Li; R Hu
Journal:  J Endocrinol Invest       Date:  2012-03-22       Impact factor: 4.256

2.  Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods.

Authors:  Sonak D Pastakia; Benson Njuguna; Beryl Ajwang' Onyango; Sierra Washington; Astrid Christoffersen-Deb; Wycliffe K Kosgei; Ponnusamy Saravanan
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-14       Impact factor: 3.007

3.  Gestational diabetes mellitus: Screening with fasting plasma glucose.

Authors:  Mukesh M Agarwal
Journal:  World J Diabetes       Date:  2016-07-25

4.  Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose.

Authors:  Mukesh M Agarwal; Gurdeep S Dhatt; Syed M Shah
Journal:  Diabetes Care       Date:  2010-06-02       Impact factor: 19.112

5.  The prognostic value of a normal oral glucose tolerance test in pregnant women who tested positive at screening: a validation study.

Authors:  Patricia M Rehder; Belmiro G Pereira; João Luiz Pinto E Silva
Journal:  Diabetol Metab Syndr       Date:  2012-04-03       Impact factor: 3.320

6.  Prediction of glucose intolerance at 24-28 weeks of gestation by glucose and insulin level measurements in the first trimester.

Authors:  Fariba Fahami; Sahar Torabi; Samereh Abdoli
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Jan-Feb

7.  Heterogeneity of glycometabolism in patients with gestational diabetes mellitus: Retrospective study of 1,683 pregnant women.

Authors:  Yan Yan; Zhou Liu; Daqing Liu
Journal:  J Diabetes Investig       Date:  2016-12-23       Impact factor: 4.232

8.  Prevalence of Gestational Diabetes Mellitus in the Middle East and North Africa, 2000-2019: A Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Rami H Al-Rifai; Noor Motea Abdo; Marília Silva Paulo; Sumanta Saha; Luai A Ahmed
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-26       Impact factor: 5.555

9.  Self-administered oral glucose tolerance test with capillary glucose measurements for the screening of diabetes mellitus in high-risk adults: a feasibility study.

Authors:  Andrew Yen Siong Tan; Mui Suan Tan; Ashley Wu; Ai Choo Seah; Cecilia Chong; Eileen Koh; Ngiap Chuan Tan
Journal:  BMJ Open Diabetes Res Care       Date:  2021-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.